{"schema_version":"secwatch.filing_event.v1","accession":"0000719135-22-000044","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2022-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.462353+00:00","generated_at":"2026-06-25T02:33:46.405766+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Apyx Medical named in securities class action over off-label product statements","bullets":["Plaintiff William Hattaway filed securities class action in Middle District of Florida on June 6, 2022.","Defendants: Apyx Medical, CEO Charles Goodwin, CFO Tara Semb; claims under Sections 10(b) and 20(a).","Allegations focus on public statements regarding off-label use of Advanced Energy products; class period May 12, 2021 - Mar 11, 2022.","Complaint seeks unspecified damages; company states allegations are without merit and will defend vigorously.","The complaint has not yet been served on the company."],"urls":{"canonical":"https://secwatch.observer/filing/0000719135-22-000044","json":"https://secwatch.observer/filing/0000719135-22-000044.json","markdown":"https://secwatch.observer/filing/0000719135-22-000044.md","text":"https://secwatch.observer/filing/0000719135-22-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000071913522000044/0000719135-22-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000071913522000044/apyx-20220607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:33:46.405766+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}